ABL1 and acute lymphoblastic leukemia: The BCR/ABL fusion protein is present in nearly all patients with chronic myelogenous leukemia (CML) and in 20% of the adult and 2–5% of the pediatric patients with B-acute lymphoblastic leukemia (B-ALL).